Central Bank Consultation Paper 175: Streamlining the PCF List – What It Means for Financial Services

The Central Bank of Ireland (the “CBI”) has published its consultation paper on amendments to the list of pre-approval controlled functions (CP175) proposing to cut the number of senior roles that need its approval before appointment by around 60%. Firms would no longer need pre-approval for 34 of the current 57 pre-approval controlled function (“PCF”) roles. 

Our Investment Management Group outlined the potential implications of CP175 for fund management companies in its briefing here: Central Bank Consultation Paper 175: Streamlining the PCF List – What It Means for Fund Management Companies.

Key takeaways

  • Fewer appointments will need CBI sign-off, saving time and cost, and making it easier to fill senior positions quickly.
  • Greater responsibility will rest with firms, as individuals performing roles no longer subject to pre-approval will continue to be subject to fitness and probity standards and must be assessed and certified by the regulated firm.
  • The current rules will continue to apply until the proposed changes take effect, which is expected to happen alongside the implementation of the outcome of the Individual Accountability Framework review in 2027.
  • Responses to the consultation are due by 17 February 2027.

Background

The proposals follow Andrea Enria’s independent review of the CBI’s Fitness and Probity Regime, which recommended a review of the number of PCF roles. The current list has grown to 57 roles across various sectors. The CBI wants to reduce administrative burden, focus its scrutiny on the most critical roles and align more closely with regimes in other jurisdictions.

Proposed changes

  • One cross-sector list: roles will no longer be listed sector by sector. For example, the separate investment roles for insurance and investment firms will merge into a single Head of Investment role, and a new Head of Credit role will cover banking and retail credit.
  • Board committee chairs removed: all board members still need approval, but chairs of the audit, risk, remuneration and nomination committees will no longer require separate approval in that capacity.
  • Safeguarding roles consolidated: the various client asset, investor money and safeguarding roles become one Head of Safeguarding Oversight role.
  • Branch roles updated: unused branch manager roles for Irish branches are removed. A new role is added for managers of Irish branches of EEA firms providing depositary or fund administration services to Irish funds.
  • Overlapping roles removed: examples include Head of Regulation and Head of Operations.
  • Designated persons replaced: fund management companies would no longer have to appoint the six designated persons. Instead, each would need at least a Chief Executive, Chief Risk Officer and Head of Investment/Chief Investment Officer. The CBI has confirmed that this change to the fund management company governance model will be consulted on separately at a later date.

Roles that remain include directors, the chair, the Chief Executive, heads of finance, compliance, internal audit, anti-money laundering and counter terrorist financing compliance, actuarial, underwriting and claims, the Chief Risk Officer, Chief Operating Officer and Chief Information Officer. Listing a role does not mean that a firm is required to create it. Rather, pre-approval applies only where the role already exists.

Unchanged obligations

Every role removed from the list remains a controlled function exercising significant influence on the firm. This means that firms must still:

  • carry out thorough due diligence and be satisfied that the individual meets the Fitness and Probity Standards before appointment;
  • certify ongoing compliance with those Standards every year;
  • ensure the individual follows the Common Conduct Standards and the Additional Conduct Standards set out in the Individual Accountability Framework; and
  • for firms within the Senior Executive Accountability Regime, consider how these role holders are reflected in their management responsibility maps.
  • The CBI expects firms to apply these standards rigorously and the CBI retains its full supervisory and enforcement toolkit. Existing approvals and applications already in progress for retained roles should not be affected.

Practical implications and next steps

  • Keep applying the current rules: until the changes take effect, appointing anyone to a currently listed PCF role without prior written CBI approval remains prohibited.
  • Identify roles exiting pre-approval: map your current role holders against the proposed list to see which roles will drop out of pre-approval.
  • Strengthen internal vetting: review your due diligence, onboarding and annual certification processes, which will carry more weight for roles no longer pre-approved.
  • Review accountability maps: firms within the Senior Executive Accountability Regime should consider how the changes affect the allocation of prescribed responsibilities.
  • Monitor the governance model changes: fund management companies should note the proposed move away from designated persons and watch for the separate consultation on the CBI’s review of the regulatory framework for fund management companies.
  • Consider responding: responses to the consultation paper can be emailed to PCFConsultation@centralbank.ie with the subject line "Response to PCF amendments" by 17 February 2027. The CBI will publish responses unless confidentiality has been requested and welcomes any requests for bilateral meetings.

Key dates

Consultation closes: 17 February 2027

Consultation on Individual Accountability Framework review: Q1 2027

CBI Feedback Statement: Q2 2027

Changes take effect with transitional arrangements: 2027 (aligned with the Individual Accountability Framework review)

How can McCann FitzGerald LLP help?

For further information on any of the matters discussed in this briefing, please contact any of the key contacts below or your usual contact at McCann FitzGerald LLP.

This document has been prepared by McCann FitzGerald LLP for general guidance only and should not be regarded as a substitute for professional advice. Such advice should always be taken before acting on any of the matters discussed.

Key Contacts